Oxford Asset Management’s Avanos Medical AVNS Stock Holding History

Oxford Asset Management’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-11,922	Closed	-$146K	–	457
2025 Q2	$146K	Buy	11,922 +684	+6%	+$8.6K	0.05%	454
2025 Q1	$161K	Buy	+11,238	New	+$175K	0.07%	382
2018 Q3	–	Sell	-28,718	Closed	-$1.64M	–	1686
2018 Q2	$1.64M	Buy	+28,718	New	+$1.52M	0.03%	779
2017 Q4	–	Sell	-69,175	Closed	-$3.15M	–	1612
2017 Q3	$3.15M	Buy	69,175 +13,761	+25%	+$587K	0.06%	382
2017 Q2	$2.18M	Sell	55,414 -10,573	-16%	-$400K	0.04%	569
2017 Q1	$2.51M	Sell	65,987 -10,203	-13%	-$398K	0.06%	357
2016 Q4	$2.82M	Sell	76,190 -19,221	-20%	-$687K	0.1%	211
2016 Q3	$3.31M	Buy	+95,411	New	+$3.34M	0.1%	261

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Oxford Asset Management's AVNS Position: Q3 2025 in Review

Oxford Asset Management sold out of Avanos Medical (AVNS) in Q3 2025, closing a stake of 11,922 shares — an estimated $146K sold.

Oxford Asset Management first reported a position in AVNS in Q3 2016 and held it in 8 quarters. The position peaked at $3.31M in Q3 2016. 276 funds tracked by Wall St. Rank hold AVNS as of Q3 2025.

Oxford Asset Management reported no remaining Avanos Medical position as of Q3 2025 after selling out during the quarter.
Oxford Asset Management sold 11,922 Avanos Medical shares in Q3 2025, an estimated $146K.
Oxford Asset Management first reported a position in Avanos Medical in Q3 2016 and held it in 8 quarters.
Oxford Asset Management's Avanos Medical position peaked at $3.31M in Q3 2016.
276 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2025.

Based on Oxford Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.